Marshall Islands vs San Marino: Share of adolescent girls vaccinated against human papillomavirus
Marshall Islands
54.0%
in 2024
San Marino
53.0%
in 2024
Marshall Islands rank
49th
San Marino rank
52nd
Share of adolescent girls vaccinated against human papillomavirus over time
- Marshall Islands
- San Marino
How they compare
Marshall Islands currently reports 54.0% against 53.0% in San Marino, a difference of 1.0%.
The two have swapped places 4 times across 9 shared years of data; in 2016 it was Marshall Islands ahead.
Marshall Islands ranks 49th and San Marino ranks 52nd of 74 countries.
Across the 2 decades both report, Marshall Islands averaged higher in 1 and San Marino in 1.
Head to head by decade
| Decade | Marshall Islands | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.2% | 22.2% | 5.0% | Marshall Islands |
| 2020s | 50.6% | 51.0% | 0.4% | San Marino |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Marshall Islands or San Marino?
- Marshall Islands, at 54.0% against 53.0% in San Marino as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Marshall Islands and San Marino?
- 1.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and San Marino?
- 9 years are reported by both, from 2016 to 2024.
- How do Marshall Islands and San Marino rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Marshall Islands ranks 49th and San Marino ranks 52nd of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.